Doxorubicin hydrochloride 阿霉素 盐酸盐
CAS 25316-40-9 MFCD00077757
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Antibiotics, Antibiotics A to Z, Antibiotics A-F, Antibiotics by Application, Antineoplastic and Immunosuppressive Antibiotics, Antiviral, Apoptosis and Cell Cycle, Chemical Structure Class, Detection, Enzyme Inhibitors, Enzyme Inhibitors by Enzyme, Fluorescent Labels, Fluorescent Stains, Interferes with DNA Synthesis, Mechanism of Action, Nucleic Acid Stains, Nucleic Acid Stains For Flow Cytometry, Other Apoptosis Related Reagents, Other Fluorescent Labels, R to Z, Reverse Transcriptase, AMV, Spectrum of Activity, Tetracyclines, Wavelength Index,
- {SNA} Antibiotics,
产品应用
- 抗肿瘤抗生素,在心脏线粒体DNA方面有阿霉素的效果。反相转录酶和RNA聚合酶的抑制剂,免疫抑制剂;可插入DNA链中。临床上是癌症化疗剂、主要用于急、慢性白血病、恶性淋巴瘤。
相关文献及参考
- Cheng, J., et al., Poly(ethylene Glycol)-conjugated Multi-walled Carbon Nanotubes As An Efficient Drug Carrier For Overcoming Multidrug Resistance. Toxicol. Appl. Pharmacol. 250 , 184-93, (2011) 摘要
- 2. R.J. White et al. Drugs Pharm. Sci. 22 , 569, (1984)
- Park, J.Y., et al., Doxorubicin Enhances CD4(+) T-cell Immune Responses By Inducing Expression Of CD40 Ligand And 4-1BB. Int. Immunopharmacol. 9 , 1530-9, (2009) 摘要
- Ahn, J., et al., Srg3, A Mouse Homolog Of BAF155, Is A Novel P53 Target And Acts As A Tumor Suppressor By Modulating P21(WAF1/CIP1) Expression. Oncogene 30 , 445-56, (2011) 摘要
- Simpson, N.E., et al., High Levels Of Hsp90 Cochaperone P23 Promote Tumor Progression And Poor Prognosis In Breast Cancer By Increasing Lymph Node Metastases And Drug Resistance. Cancer Res. 70 , 8446-56, (2010) 摘要
- Friesen, C., et al., Cytotoxic drugs and the CD95 pathway. Leukemia 13 , 1854, (1999)
- Venkatachalam, K., et al., Neutralization Of Interleukin-18 Ameliorates Ischemia/reperfusion-induced Myocardial Injury. J. Thorac. Cardiovasc. Surg. 284 , 7853-65, (2009) 摘要
- Merck: 14,3439
- Benson, E.K., et al., Role Of Progerin-induced Telomere Dysfunction In HGPS Premature Cellular Senescence. J. Cell Biol. 123 , 2605-12, (2010) 摘要
- Rajagopal, A., and Simon, S.M. Mol. Biol. Cell 14 , 3389-3399, (2003) 摘要
安全信息
GHS Symbol
- H302 Harmful if swallowed 吞食有害
- H315 Causes skin irritation 会刺激皮肤
- H319 Causes serious eye irritation 严重刺激眼睛
- H350 May cause cancer 可能致癌
- P201 Obtain special instructions before use. 使用前获取专门指示。
- P202 Do not handle until all safety precautions have been read and understood. 已阅读并理解所有的安全预防措施之前,切勿操作。
- P260 Do not breathe dust/fume/gas/mist/vapours/spray. 不要吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
- P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
- P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
- P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
- P301+P312+P330
- P305+P351+P338
- P308+P313
- P405 Store locked up. 上锁保管。
- P501 Dispose of contents/container to..… 处理内容物/容器.....
- S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);
- S53 Avoid exposure - obtain special instructions before use 避免接触,使用前获得特别指示说明;
- R22 Harmful if swallowed 吞咽有害
- R36/38 Irritating to eyes and skin 对眼睛和皮肤有刺激性
- R45 May cause cancer 可能致癌
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Primate - monkey DOSE/DURATION : 27 mg/kg/2Y-I TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Blood - leukemia REFERENCE : PHMGBN Pharmacology: International Journal of Experimental and Clinical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1968- Volume(issue)/page/year: 20,9,1980
TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Human - man DOSE/DURATION : 2571 ug/kg/3W-I TOXIC EFFECTS : Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) REFERENCE : AIMDAP Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- Volume(issue)/page/year: 137,385,1977
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 1245 ug/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 5980 ug/kg TOXIC EFFECTS : Behavioral - food intake (animal) Behavioral - muscle weakness REFERENCE : KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 7,1052,1973
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPO
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 16030 ug/kg TOXIC EFFECTS : Gastrointestinal - hypermotility, diarrhea Skin and Appendages - dermatitis, allergic (after topical exposure) Nutritional and Gross Metabolic - weight loss
TYPE OF TEST : Phage inhibition capacity TEST SYSTEM : Bacteria - Escherichia coli DOSE/DURATION : 350 ug/L REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 77,197,1980
TYPE OF TEST : DNA repair TEST SYSTEM : Bacteria - Escherichia coli DOSE/D
TYPE OF TEST : Sex chromosome loss and nondisjunction TEST SYSTEM : Non-mammalian species Testis DOSE/DURATION : 2 umol/L REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 247,29,1991
TYPE OF TEST : Mutation in microorganisms TEST SYSTEM : Bacteria - Salmonella typhimurium DOSE/DURATION : 700 ng/plate REFERENCE : AJHPA9 A
TYPE OF TEST : Cytogenetic analysis TEST SYSTEM : Non-mammalian species Cells - not otherwise specified DOSE/DURATION : 200 nmol/L REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 247,29,1991
TYPE OF TEST : Cytogenetic analysis TEST SYSTEM : Non-mammalian species Testis DOSE/DURATION : 2 umol/L REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 247,29,1991
{hazar
TYPE OF TEST : Sister chromatid exchange TEST SYSTEM : Human Lymphocyte DOSE/DURATION : 100 nmol/L REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 45,343,1977
TYPE OF TEST
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rabbit DOSE : 30 mg/kg SEX/DURATION : male 30 day(s) pre-mating TOXIC EFFECTS : Reproductive - Paternal Effects - testes, epididymis, sperm duct REFERENCE : KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 7,1063,1973
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE : 6 mg/kg SEX/DURATION : male 2 week(s) pre-mating TOXIC EFFECTS : Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count) Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Paternal Effects - prostate, seminal vesicle, Cowper's gland, accessory glands REFERENCE : REPTED Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- Volume(issue)/page/year: 2,117,1988
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE : 4500 ug/kg SEX/DURATION : male 5 week(s) pre-mating TOXIC EFFECTS : Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count) Reproductive - Paternal Effects - testes, epididymis, sperm duct REFERENCE : ANDRDQ Andrologia. (Grosse Verlag GmbH, Kurfuerstenstr. 112-113, D-1000 Berlin 30, Fed. Rep. Ger.) V.6- 1974- Volume(issue)/page/year: 26,151,1994
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE
其他信息
- MOL 文件:25316-40-9.mol
- Doxorubicin (Adriamycin)是一种抗生素类试剂,抑制DNA拓扑异构酶II,且诱导DNA损伤和凋亡。
- 上游原料:柔红霉素
- EPA Substance Registry System:25316-40-9(EPA Substance)
- 方法一:由松链丝菌浅灰色变株(Str.Peucetius var.Caesius)的培养液提取而得。本品化学结构与柔红霉素类似,因此可以由柔红霉素化学转化而制得。目前已可化学全合成。
- 溶于水、DMSO、四氢呋喃和醇,不溶于丙酮、苯、氯仿、乙醚。水中溶解度: 10 mg/mL, 水溶液为橙红色透明溶液。
- F:10-21
- 用途一:癌症化疗剂、主要用于急、慢性白血病、恶性淋巴瘤。
- 用途二:抗肿瘤抗生素,在心脏线粒体DNA方面有阿霉素的效果。反相转录酶和RNA聚合酶的抑制剂,免疫抑制剂;可插入DNA链中。临床上是癌症化疗剂、主要用于急、慢性白血病、恶性淋巴瘤。
- 下游产品:吡柔比星